questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérobicycliques
Benzofuranes
Benzofuranes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Substance-Related Disorders
Diagnostic
5
Intoxication
Tests toxicologiques
Analyse de sang
Analyse d'urine
Symptômes
Troubles neurologiques
Tests de dépistage
Benzofuranes
Historique médical
Exposition
Symptômes
5
Effets psychologiques
Anxiété
Éruptions cutanées
Démangeaisons
Système respiratoire
Irritation
Prévention
5
Prévention
Équipements de protection
Mesures de sécurité
Laboratoire
Gestion des déchets
Déchets dangereux
Traitements
5
Intoxication
Soins symptomatiques
Symptômes neurologiques
Médicaments
Soins d'urgence
Exposition
Décontamination
Absorption
Complications
5
Complications
Neurologiques
Maladies chroniques
Exposition prolongée
Effets à long terme
Troubles cognitifs
Reproduction
Effets néfastes
Suivi médical
Complications
Facteurs de risque
5
Travailleurs
Produits chimiques
Produits chimiques
Médicaments
Antécédents médicaux
Maladies respiratoires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Benzofuranes : Questions médicales les plus fréquentes",
"headline": "Benzofuranes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Benzofuranes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-05",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Benzofuranes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétérobicycliques",
"url": "https://questionsmedicales.fr/mesh/D006574",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétérobicycliques",
"code": {
"@type": "MedicalCode",
"code": "D006574",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Amiodarone",
"alternateName": "Amiodarone",
"url": "https://questionsmedicales.fr/mesh/D000638",
"about": {
"@type": "MedicalCondition",
"name": "Amiodarone",
"code": {
"@type": "MedicalCode",
"code": "D000638",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.075"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dronédarone",
"alternateName": "Dronedarone",
"url": "https://questionsmedicales.fr/mesh/D000077764",
"about": {
"@type": "MedicalCondition",
"name": "Dronédarone",
"code": {
"@type": "MedicalCode",
"code": "D000077764",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.075.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Benzbromarone",
"alternateName": "Benzbromarone",
"url": "https://questionsmedicales.fr/mesh/D001553",
"about": {
"@type": "MedicalCondition",
"name": "Benzbromarone",
"code": {
"@type": "MedicalCode",
"code": "D001553",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.110"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cantharidine",
"alternateName": "Cantharidin",
"url": "https://questionsmedicales.fr/mesh/D002193",
"about": {
"@type": "MedicalCondition",
"name": "Cantharidine",
"code": {
"@type": "MedicalCode",
"code": "D002193",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.125"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Citalopram",
"alternateName": "Citalopram",
"url": "https://questionsmedicales.fr/mesh/D015283",
"about": {
"@type": "MedicalCondition",
"name": "Citalopram",
"code": {
"@type": "MedicalCode",
"code": "D015283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.187"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Escitalopram",
"alternateName": "Escitalopram",
"url": "https://questionsmedicales.fr/mesh/D000089983",
"about": {
"@type": "MedicalCondition",
"name": "Escitalopram",
"code": {
"@type": "MedicalCode",
"code": "D000089983",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.203"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fura-2",
"alternateName": "Fura-2",
"url": "https://questionsmedicales.fr/mesh/D016257",
"about": {
"@type": "MedicalCondition",
"name": "Fura-2",
"code": {
"@type": "MedicalCode",
"code": "D016257",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Griséofulvine",
"alternateName": "Griseofulvin",
"url": "https://questionsmedicales.fr/mesh/D006118",
"about": {
"@type": "MedicalCondition",
"name": "Griséofulvine",
"code": {
"@type": "MedicalCode",
"code": "D006118",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.275"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Benzofuranes",
"alternateName": "Benzofurans",
"code": {
"@type": "MedicalCode",
"code": "D001572",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Zhi Xu",
"url": "https://questionsmedicales.fr/author/Zhi%20Xu",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, Guizhou, P.R. China."
}
},
{
"@type": "Person",
"name": "Wei Zhou",
"url": "https://questionsmedicales.fr/author/Wei%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, Guizhou Medical University, Guiyang 550025, Guizhou, P.R. China."
}
},
{
"@type": "Person",
"name": "Ashraf A Abbas",
"url": "https://questionsmedicales.fr/author/Ashraf%20A%20Abbas",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602."
}
},
{
"@type": "Person",
"name": "Kamal M Dawood",
"url": "https://questionsmedicales.fr/author/Kamal%20M%20Dawood",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602."
}
},
{
"@type": "Person",
"name": "Giovanni Luca Beretta",
"url": "https://questionsmedicales.fr/author/Giovanni%20Luca%20Beretta",
"affiliation": {
"@type": "Organization",
"name": "Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Tumori, Via Amadeo 42, 20133 Milan, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Family members' experiences of caring for a relative with substance-induced psychosis disorder.",
"datePublished": "2022-11-21",
"url": "https://questionsmedicales.fr/article/36453821",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4102/curationis.v45i1.2348"
}
},
{
"@type": "ScholarlyArticle",
"name": "COVID-19-Related Death in Patients with Alcohol or Substance Use Disorders.",
"datePublished": "2022-11-30",
"url": "https://questionsmedicales.fr/article/36450270",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000527542"
}
},
{
"@type": "ScholarlyArticle",
"name": "Substance Use Disorder.",
"datePublished": "2023-08-05",
"url": "https://questionsmedicales.fr/article/37977753",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.emc.2023.06.023"
}
},
{
"@type": "ScholarlyArticle",
"name": "Provision of health care services related to substance use disorder in southern U.S. jails.",
"datePublished": "2023-12-05",
"url": "https://questionsmedicales.fr/article/38061634",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.josat.2023.209234"
}
},
{
"@type": "ScholarlyArticle",
"name": "Substance Use Disorder-Related Deaths and Maternal Mortality in New Mexico, 2015-2019.",
"datePublished": "2023-06-12",
"url": "https://questionsmedicales.fr/article/37306823",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10995-023-03691-8"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Benzofuranes",
"item": "https://questionsmedicales.fr/mesh/D001572"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Benzofuranes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Benzofuranes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Benzofuranes",
"description": "Comment diagnostiquer une intoxication aux benzofuranes ?\nQuels tests sont utilisés pour détecter les benzofuranes ?\nQuels symptômes indiquent une exposition aux benzofuranes ?\nLes benzofuranes sont-ils visibles sur des tests standards ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Substance-Related+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Benzofuranes",
"description": "Quels sont les symptômes courants des benzofuranes ?\nLes benzofuranes provoquent-ils des effets psychologiques ?\nY a-t-il des symptômes cutanés associés aux benzofuranes ?\nLes benzofuranes affectent-ils le système respiratoire ?\nLes symptômes varient-ils selon la dose de benzofuranes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Substance-Related+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Benzofuranes",
"description": "Comment prévenir l'exposition aux benzofuranes ?\nLes travailleurs doivent-ils être formés sur les benzofuranes ?\nQuelles mesures de sécurité sont recommandées en laboratoire ?\nLes benzofuranes sont-ils réglementés ?\nComment gérer les déchets contenant des benzofuranes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Substance-Related+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Benzofuranes",
"description": "Quel traitement est recommandé pour l'intoxication aux benzofuranes ?\nDes antidotes existent-ils pour les benzofuranes ?\nComment traiter les symptômes neurologiques causés par les benzofuranes ?\nLes soins d'urgence sont-ils nécessaires pour l'exposition aux benzofuranes ?\nLa décontamination est-elle nécessaire après exposition ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Substance-Related+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Benzofuranes",
"description": "Quelles complications peuvent survenir après exposition aux benzofuranes ?\nLes benzofuranes peuvent-ils causer des maladies chroniques ?\nY a-t-il des effets à long terme des benzofuranes ?\nLes benzofuranes peuvent-ils affecter la reproduction ?\nComment surveiller les complications liées aux benzofuranes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Substance-Related+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Benzofuranes",
"description": "Qui est à risque d'exposition aux benzofuranes ?\nLes benzofuranes sont-ils présents dans des produits courants ?\nL'âge influence-t-il la sensibilité aux benzofuranes ?\nLes antécédents médicaux augmentent-ils le risque ?\nLes benzofuranes affectent-ils différemment les sexes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Substance-Related+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux benzofuranes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et les tests toxicologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les benzofuranes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter ces composés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition aux benzofuranes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles neurologiques, des nausées et des palpitations."
}
},
{
"@type": "Question",
"name": "Les benzofuranes sont-ils visibles sur des tests standards ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, des tests spécifiques sont nécessaires pour détecter les benzofuranes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à établir un lien entre les symptômes et l'exposition aux benzofuranes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des benzofuranes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des vertiges, des maux de tête et des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Les benzofuranes provoquent-ils des effets psychologiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent causer de l'anxiété, des hallucinations et des troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés aux benzofuranes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées et des démangeaisons peuvent survenir après exposition."
}
},
{
"@type": "Question",
"name": "Les benzofuranes affectent-ils le système respiratoire ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent provoquer des difficultés respiratoires et une irritation des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la dose de benzofuranes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux benzofuranes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection et suivre les protocoles de sécurité en laboratoire."
}
},
{
"@type": "Question",
"name": "Les travailleurs doivent-ils être formés sur les benzofuranes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité sont recommandées en laboratoire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des hottes, des gants et des lunettes de protection lors de la manipulation."
}
},
{
"@type": "Question",
"name": "Les benzofuranes sont-ils réglementés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur utilisation est souvent réglementée en raison de leur toxicité potentielle."
}
},
{
"@type": "Question",
"name": "Comment gérer les déchets contenant des benzofuranes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les déchets doivent être éliminés selon les protocoles de gestion des déchets dangereux."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé pour l'intoxication aux benzofuranes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend l'élimination de l'exposition et des soins symptomatiques."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les benzofuranes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas d'antidote spécifique pour les benzofuranes."
}
},
{
"@type": "Question",
"name": "Comment traiter les symptômes neurologiques causés par les benzofuranes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour gérer les symptômes neurologiques."
}
},
{
"@type": "Question",
"name": "Les soins d'urgence sont-ils nécessaires pour l'exposition aux benzofuranes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins d'urgence peuvent être nécessaires en cas d'exposition sévère."
}
},
{
"@type": "Question",
"name": "La décontamination est-elle nécessaire après exposition ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la décontamination est essentielle pour réduire l'absorption des benzofuranes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition aux benzofuranes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques, respiratoires et dermatologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les benzofuranes peuvent-ils causer des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut augmenter le risque de maladies chroniques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme des benzofuranes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets à long terme incluent des troubles cognitifs et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Les benzofuranes peuvent-ils affecter la reproduction ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent qu'ils peuvent avoir des effets néfastes sur la reproduction."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications liées aux benzofuranes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier est recommandé pour détecter les complications précoces."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'exposition aux benzofuranes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs en laboratoire et ceux manipulant des produits chimiques sont à risque."
}
},
{
"@type": "Question",
"name": "Les benzofuranes sont-ils présents dans des produits courants ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être présents dans certains produits chimiques et médicaments."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la sensibilité aux benzofuranes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées peuvent être plus sensibles."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires ou neurologiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les benzofuranes affectent-ils différemment les sexes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que les effets peuvent varier entre les sexes, mais les données sont limitées."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 01/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, Guizhou, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guizhou Medical University, Guiyang 550025, Guizhou, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Tumori, Via Amadeo 42, 20133 Milan, Italy.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, Via Celoria 2, 20133 Milan, Italy.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, Via Celoria 2, 20133 Milan, Italy.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Indian Institute of Technology Guwahati Assam 781039 India span@iitg.ac.in https://www.iitg.ac.in/span/.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Institute of Chemical Technology Mumbai IOC Odisha Campus Bhubaneswar Bhubaneswar 751013 India.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Institute of Chemical Technology Mumbai IOC Odisha Campus Bhubaneswar Bhubaneswar 751013 India.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Indian Institute of Technology Guwahati Assam 781039 India span@iitg.ac.in https://www.iitg.ac.in/span/.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangzhou 510006, China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangzhou 510006, China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangzhou 510006, China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Central laboratory, The NO.1 Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming 650021, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Institute of Organic Chemistry of Polish Academy of Sciences, Kasprzaka 44/52, 01-224, Warsaw, Poland.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Government College University Faisalabad, 38000 Faisalabad, Pakistan.
Publications dans "Benzofuranes" :
When there is a lack of resources in the community to support deinstitutionalisation, family members of a relative diagnosed with substance-induced psychosis disorder (SIPD) are the most affected and ...
To explore and describe family members' experiences caring for a relative with SIPD....
The study employed a qualitative research design using interpretative phenomenological analysis as the research method. Telephonic interviews were conducted and analysed. Eight family members were sel...
The analysis of data led to the emergence of the following themes: family members experienced caring for a relative with SIPD as a destabilising responsibility; they experienced acceptance and support...
The study's findings highlighted the family members' experiences of caring for a relative with SIPD and the role of the family, community and government structures in caring for an individual with SIP...
People with substance or alcohol use disorders (SUDs/AUDs) are likely to be more vulnerable to COVID-19 infection than the general population, but the evidence of COVID-19-related mortality in these p...
The aim of the study was to verify whether patients with AUD and SUD have a higher mortality rate for COVID-19-related mortality compared to the general population....
We performed a follow-up study to assess mortality in 2020 in a cohort of patients diagnosed for the first time with AUDs or SUDs at the Public Health Services in the metropolitan area of Bologna (Nor...
SUDs/AUDs patients present an excess mortality with respect to the general population for all causes of death and for COVID-19-related mortality....
Our data support the need for prevention strategies in SUDs/AUDs patients such as vaccinations....
Substance use disorders (SUDs) present a challenge in the emergency department (ED) setting. This article provides an overview of SUDs, their clinical assessment, legal considerations in drug testing,...
The U.S. jail population has more than tripled since the 1980s, and today, one out of every three incarcerated individuals is being held in a county or city jail. Substance use disorders (SUD) are ove...
We conducted a thematic analysis of qualitative data from 34 interviews conducted with 38 personnel from a purposive sample of jails that varied in size and rurality within a five-state study area. Th...
Interviewees described wide variability in both availability and comprehensiveness of SUD-related health care services. Most adhered to federal guidance for supervising withdrawal from alcohol and ben...
This study identified several areas where jails could improve SUD-related health care services. Many of the barriers to improvement-organizational buy-in, cost/budgeting, staffing, logistics-were not ...
In recent decades, maternal mortality has increased across the U.S. Experiences of pregnant and postpartum people with Substance Use Disorder (SUD)-related deaths have not been previously evaluated in...
We conducted an analysis of pregnancy-associated deaths to assess the association between demographics, pregnancy factors, circumstances surrounding death, treatment of mental health conditions, and e...
People with SUD-related deaths were more likely to die 43-365 days postpartum (81% vs. 45%, p-value = 0.002), have had a primary cause of death of mental health conditions (47% vs 10%, p < 0.001), hav...
Providers, health departments, and community organizations must prioritize supporting people using substances during and after pregnancy to prevent death and improve quality of life for pregnant and p...
This longitudinal study identified profiles of patients with substance-related disorders (SRD) who did or did not drop out of specialized addiction treatment, integrating various patterns of outpatien...
Substance use disorder (SUD) is among the leading causes of premature morbidity and mortality and imposes significant health, economic, and social burdens. Gender differences have been found in the de...
The population of elderly in the United States with substance use disorders (SUDs) is growing appreciably. SUDs among the elderly are often associated with poor outcomes and are frequently underdiagno...
Recognizing the specific factors in relapse disorders related to each substance can help improve treatment methods and adopt more effective preventive strategies. This study aimed to compare the situa...
This study was a cross-section type....
The study participants were 150 clients with SRDs and 150 with opiate-related disorders. Samples were selected using two stages random sampling method. Data were collected through a demographic questi...
The mean score of IDTS in the two groups was significantly different (X̄...
This study reveals that despite some similarities, relapse-related situational factors in opiates and stimulants differ. Some situational factors, such as social pressure and coping with unpleasant em...
Despite significant negative outcomes, the co-occurrence of personality disorders (PDs) and substance use disorders (SUDs) continues to be underrecognized, and the mechanisms contributing to this co-o...
The prevalence of co-occurring PD-SUD is generally high, with estimates ranging depending on the type of PD and SUD, the population assessed, and the sampling methods and measures used. Current theore...